Cargando…

Functionalized Graphene Oxide Mediated Adriamycin Delivery and miR-21 Gene Silencing to Overcome Tumor Multidrug Resistance In Vitro

Multidrug resistance (MDR) is a major impediment to successful cancer chemotherapy. Co-delivery of novel MDR-reversing agents and anticancer drugs to cancer cells holds great promise for cancer treatment. MicroRNA-21 (miR-21) overexpression is associated with the development and progression of MDR i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhi, Feng, Dong, Haifeng, Jia, Xuefeng, Guo, Wenjie, Lu, Huiting, Yang, Yilin, Ju, Huangxian, Zhang, Xueji, Hu, Yiqiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603917/ https://www.ncbi.nlm.nih.gov/pubmed/23527297 http://dx.doi.org/10.1371/journal.pone.0060034

Ejemplares similares

NanoBiosensing: Principles, Development and Application
por: Ju, Huangxian, et al.
Publicado: (2011)

Targeted multidrug delivery system to overcome chemoresistance in breast cancer
por: Tang, Yuan, et al.
Publicado: (2017)

Overcoming multidrug-resistance in vitro and in vivo using the novel P-glycoprotein inhibitor 1416
por: Xu, Yan, et al.
Publicado: (2012)

Polymeric mixed micelles loaded mitoxantrone for overcoming multidrug resistance in breast cancer via photodynamic therapy
por: Li, Zeyong, et al.
Publicado: (2017)

RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation
por: HE, MIAO, et al.
Publicado: (2013)

RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation
por: He, Miao, et al.
Publicado: (2022)

Transdermal Delivery of Adriamycin to Transplanted Ehrlich Ascites Tumor in Mice
por: Shiozuka, Masataka, et al.
Publicado: (2013)

Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures
por: Raniolo, Sofia, et al.
Publicado: (2021)

Three-dimensional Nitrogen-Doped Graphene Supported Molybdenum Disulfide Nanoparticles as an Advanced Catalyst for Hydrogen Evolution Reaction
por: Dong, Haifeng, et al.
Publicado: (2015)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Germacrone reverses Adriamycin resistance through cell apoptosis in multidrug-resistant breast cancer cells
por: XIE, XIAO-HONG, et al.
Publicado: (2014)

WYE-354 restores Adriamycin sensitivity in multidrug-resistant acute myeloid leukemia cell lines
por: Ibrahim, Sara M., et al.
Publicado: (2019)

Concurrent silencing of TBCE and drug delivery to overcome platinum-based resistance in liver cancer
por: Li, Senlin, et al.
Publicado: (2023)

Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance
por: Bortolotti, Sonia, et al.
Publicado: (2023)

Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance
por: Zhang, DanDan, et al.
Publicado: (2017)

Label-Free Quantitative Proteomics Analysis of Adriamycin Selected Multidrug Resistant Human Lung Cancer Cells
por: Efeoglu, Esen, et al.
Publicado: (2022)

Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.
por: Klugmann, F. B., et al.
Publicado: (1986)

Silencing of ETS1 reverses adriamycin resistance in MCF-7/ADR cells via downregulation of MDR1
por: Wei, Jinrong, et al.
Publicado: (2014)

Delivery of Lymph Node‐targeted Adriamycin by Gastric Submucosal Liposomal Injection in Rabbits
por: Akamo, Yoshimi, et al.
Publicado: (1993)

Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line
por: Li, Jie, et al.
Publicado: (2001)

Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
por: Coldwell, Kate E., et al.
Publicado: (2008)

Overcoming Multidrug Resistance in Cancer Stem Cells
por: Moitra, Karobi
Publicado: (2015)

Pharmacological Strategies for Overcoming Multidrug Resistance to Chemotherapy
por: Fedotcheva, T. A., et al.
Publicado: (2023)

Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance
por: Yu, Xiwei, et al.
Publicado: (2015)

A simple reduction-sensitive micelles co-delivery of paclitaxel and dasatinib to overcome tumor multidrug resistance
por: Li, Jun, et al.
Publicado: (2017)

Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer
por: Qi, Min, et al.
Publicado: (2021)

Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer
por: Hong, Woo Sung, et al.
Publicado: (2013)

Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics
por: Lin, Gan, et al.
Publicado: (2016)

Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance
por: Zhou, Lei, et al.
Publicado: (2018)

Synthesis and Anticancer Cytotoxicity of Azaaurones Overcoming Multidrug Resistance
por: Tóth, Szilárd, et al.
Publicado: (2020)

Overcoming Multidrug Resistance of Antibiotics via Nanodelivery Systems
por: Imran, Mohammad, et al.
Publicado: (2022)

Downregulated miR-130a enhances the sensitivity of acute myeloid leukemia cells to Adriamycin
por: Liu, Huimin, et al.
Publicado: (2020)

Graphene-Based Biosensors for Detection of Biomarkers
por: Bai, Yunlong, et al.
Publicado: (2020)

Adriamycin cardiotoxicity monitoring by radionuclide scan.
por: Robinson, B. A., et al.
Publicado: (1983)

Lipid–Saporin Nanoparticles for the Intracellular Delivery of Cytotoxic Protein to Overcome ABC Transporter-Mediated Multidrug Resistance In Vitro and In Vivo
por: Zhang, Guan-Nan, et al.
Publicado: (2020)

Mechanism of the enhancing effects of miR-93 on resistance of breast cancer MCF-7 cells to adriamycin
por: Wang, Qian, et al.
Publicado: (2018)

Downregulation of hypermethylated in cancer-1 by miR-4532 promotes adriamycin resistance in breast cancer cells
por: Feng, Fan, et al.
Publicado: (2018)

MiR-367 negatively regulates apoptosis induced by adriamycin in osteosarcoma cells by targeting KLF4
por: Wang, Guang-Chao, et al.
Publicado: (2016)

Enhanced therapeutic effect of Adriamycin on multidrug resistant breast cancer by the ABCG2-siRNA loaded polymeric nanoparticles assisted with ultrasound
por: Bai, Min, et al.
Publicado: (2015)

Overcoming Multidrug Resistance in Human Cancer Cells by Natural Compounds
por: Nabekura, Tomohiro
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_94c82u0sl90v84btc5p74igodd